Drug recall · January 22, 2014
PEGASPARGASE ONCASPAR Injection recall
Why: Lack of Assurance of Sterility: Sigma-Tau PharmaSource, Inc. is conducting a voluntary recall of five lots of Oncaspar Injection, because of a crack under the crimp seal which caused a leak.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
PEGASPARGASE ONCASPAR Injection, 3750 International Units Per 5mL vial, Rx ONLY, sigma-tau PHARMACEUTICALS INC, 9841 Washingtonian Blvd, Gaithersburg, MD 20878 NDC 54482-301-01
- Lots / codes
Lot# 3012A, 3013A, 30138, Exp. 11/13 Lot# 3014A, 3014A CLIN, Exp. 12/13
- Quantity
- 7479 vials
- Company
- Sigma-Tau Pharmaceuticals, Inc., Gaithersburg, MD
- Distribution
- Nationwide
- Initiated
- November 1, 2013 · Voluntary: Firm initiated
- Classified
- January 15, 2014
- Reported
- January 22, 2014
- Ended
- December 18, 2014
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.